Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.

Jorgensen, J H

Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. [electronic resource] - Antimicrobial agents and chemotherapy Feb 1999 - 329-34 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0066-4804

10.1128/AAC.43.2.329 doi


Anti-Infective Agents--pharmacology
Bacterial Proteins--genetics
DNA Gyrase
DNA Topoisomerase IV
DNA Topoisomerases, Type II--genetics
DNA-Binding Proteins--genetics
Drug Resistance, Microbial--genetics
Humans
Levofloxacin
Microbial Sensitivity Tests
Molecular Sequence Data
Mutation
Ofloxacin--pharmacology
Streptococcus pneumoniae--drug effects